NEW YORK, March 15 – Oxford Glycosciences of Oxford, UK, has apparently changed its plans for entering the protein microarray market, saying Thursday that their collaboration with Packard Biosciences and Cambridge Antibody Technologies is “just a research project” and that the company has no immediate plans to commercialize the technology. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.